Alster TS, Bryan H, Williams CM Long-pulsed Nd:YAG laser-assisted hair removal in pigmented skin: a clinical and histological evaluation. Arch Dermatol. 2001 Jul;137(7):885-9.
Bronner AK, Hood AF Cutaneous complications of chemotherapeutic agents. J Am Acad Dermatol. 1983 Nov;9(5):645-63.
Garcia-Zuazaga J Pseudofolliculitis barbae: review and update on new treatment modalities. Mil Med. 2003 Jul;168(7):561-4. Review.
Guardiano RA, Norwood CW Direct comparison of EMLA versus lidocaine for pain control in Nd:YAG 1,064 nm laser hair removal. Dermatol Surg. 2005 Apr;31(4):396-8. Erratum in: Dermatol Surg. 2005 Dec;31(12):1747.
Lanigan SW Incidence of side effects after laser hair removal. J Am Acad Dermatol. 2003 Nov;49(5):882-6.
Lim SP, Lanigan SW A review of the adverse effects of laser hair removal. Lasers Med Sci. 2006 Sep;21(3):121-5. Epub 2006 Jul 1. Review.
Weaver SM 3rd, Sagaral EC Treatment of pseudofolliculitis barbae using the long-pulse Nd:YAG laser on skin types V and VI. Dermatol Surg. 2003 Dec;29(12):1187-91.
Weinstein GD, Mooney KM Cell proliferation kinetics in the human hair root. J Invest Dermatol. 1980 Jan;74(1):43-6.
Clinical Safety and Efficacy of Prototype Devices for Hair Growth Control: Task 2.4
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
